Mr. David Thomas Schumann Profile

David Thomas Schumann

at Synergy Energy Systems LLC

SPIE Involvement:

Author

Publications (1)

This will count as one of your downloads.

You will have access to both the presentation and article (if available).

DOWNLOAD NOW

This content is available for download via your institution's subscription. To access this item, please sign in to your personal account.

Email or Username Forgot your username?

Password Forgot your password?

Show

Keep me signed in

No SPIE account? Create an account

Proceedings Article | 5 March 2021 Presentation + Paper

Progress toward a VUV Raman spectrometer to detect pathogens

Sanja Dmitrovic, Brian Molnar, Young Sik Kim, David Schumann, James Foley, Jacob Shelley, Tom Milster

Proceedings Volume 11655, 116551G (2021) https://doi.org/10.1117/12.2583347

Read Abstract +

Rapid detection and identification of novel viruses, such as SARS-CoV-2, is critical to treat, isolate, or hospitalize those infected, ultimately, to curb the spread of the virus. Diagnostic assays, such as enzyme-linked immunosorbent assay (ELISA) and polymerase chain reaction (PCR), are considered the gold standard for testing, but are labor-intensive and/or involve creating probe molecules specific to the virus. We propose Raman spectroscopy as an alternative method of detection because it can be label-free and can offer identifying information on many analytes within a sample. Specifically, we are developing a vacuum ultraviolet (VUV) Raman spectrometer using an incoherent excitation source that emits the hydrogen Lyman-α line radiation at 121.57 nm. The main benefit of using a VUV source is that the Raman scattering cross-section is inversely proportional to the fourth power of wavelength, which means that VUV photons would yield several orders of magnitude higher scattering cross-sections than excitation in the visible or near-infrared. In addition, the 121.57 nm wavelength transmits up to 2 cm in dry air, so the analyte can be oriented in standard testing formats. We have been successful in producing strong and consistent HLA emission using both a dielectric-barrier discharge (DBD) plasma source and a commercial source. In the near future, we expect to produce consistent Raman signatures in solid and liquid media. HLAS will transform diagnostic medicine and several other industries through its powerful capabilities of detecting real-time infections and important health markers.

My Library

You currently do not have any folders to save your paper to! Create a new folder below.

Folder Name

Folder Description

View contact details

UPDATE YOUR PROFILE

Is this your profile? Update it now.

Sign into your SPIE.org account

Don’t have a profile and want one?

Create an account on SPIE.org

Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks. You are receiving this notice because your organization may not have SPIE eBooks access.*

*Shibboleth/Open Athens users─please sign in to access your institution's subscriptions.

To obtain this item, you may purchase the complete book in print or electronic format on SPIE.org.

ORGANIZATIONAL
Sign in with credentials provided by your organization.

Organizational Username

Organizational Password

Show/Hide Password

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

;

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available

Members:

Non-members: ADD TO CART

Keywords/Phrases

Search In:

Publication Years